Skip to main content
Fig. 1 | Malaria Journal

Fig. 1

From: Terminalia albida treatment improves survival in experimental cerebral malaria through reactive oxygen species scavenging and anti-inflammatory properties

Fig. 1

Antiplasmodial activity of Terminalia albida treatment in ECM model. C57BL/6 mice were infected with P. berghei ANKA and treated 2 h later with chloroquine (5 mg/kg), Terminalia albida crude extract (100 mg/kg) or water (25 mL/kg) from Day 0 to Day 3. a Mean parasite densities during infection. b Percentages of parasite suppression according to the treatment, calculated by comparison to H2O treated mice. **P < 0.005, ***P < 0.0005 compared Terminalia albida to H2O group

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us